STOCK TITAN

BlackRock, Inc. (NYSE: BLK) general counsel exercises 18,095 options and sells shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BlackRock, Inc. executive Christopher J. Meade, General Counsel and CLO, exercised 18,095 employee stock options at an exercise price of $513.50 per share on July 16, 2026, acquiring the same number of common shares. On the same date he sold an aggregate 18,095 common shares in two transactions at weighted-average prices of $1,101.9936 and $1,102.7963 per share, each executed through multiple trades within narrow price ranges.

After these transactions, he directly holds 14,059 common shares, which include Restricted Stock Units that will vest over 1 to 3 years; each Restricted Stock Unit is payable solely in one share of common stock.

Positive

  • None.

Negative

  • None.
Insider Meade Christopher J.
Role General Counsel and CLO
Sold 18,095 shs ($19.94M)
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) 18,095 $0.00 --
Exercise Common Stock 18,095 $513.50 $9.29M
Sale Common Stock 15,895 $1,101.9936 $17.52M
Sale Common Stock 2,200 $1,102.7963 $2.43M
Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 32,154 shares (Direct)
Footnotes (1)
  1. Includes Common Stock as well as Restricted Stock Units that will vest over a period of 1 to 3 years. Each Restricted Stock Unit is payable solely by delivery of an equal number of shares of Common Stock. This transaction was executed in multiple trades at prices ranging from $1,101.43 to $1,102.34. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $1,102.76 to $1,102.89. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price. These options vested in equal installments on December 4, 2022, December 4, 2023 and December 4, 2024.
Options exercised 18095.0000 shares Employee Stock Options exercised into common stock on 2026-07-16 at $513.5000 per share
Option exercise price $513.5000 per share Exercise price for 18095.0000 Employee Stock Options exercised on 2026-07-16
Shares sold (first tranche) 15895.0000 shares Common Stock sold on 2026-07-16 at weighted-average price $1101.9936 per share
Shares sold (second tranche) 2200.0000 shares Common Stock sold on 2026-07-16 at weighted-average price $1102.7963 per share
Post-transaction holdings 14059.0000 shares Directly held Common Stock (including RSUs) after transactions reported for 2026-07-16
Option expiration date 2026-12-04 Expiration date of Employee Stock Options that were fully exercised for 18095.0000 shares
Restricted Stock Units financial
"Includes Common Stock as well as Restricted Stock Units that will vest over a period"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Option financial
"Employee Stock Option (Right to Buy) with an expiration date of 2026-12-04"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
weighted average sale price financial
"The price reported represents the weighted average sale price of these trades"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider stock activity did BlackRock (BLK) report for Christopher J. Meade?

Christopher J. Meade exercised 18,095 options at $513.50 per share and sold 18,095 common shares in two transactions at weighted-average prices of $1,101.9936 and $1,102.7963 per share, all on July 16, 2026.

How many BlackRock (BLK) shares does Christopher J. Meade hold after this Form 4?

Following the reported transactions, Christopher J. Meade directly holds 14,059 BlackRock common shares. This figure includes Restricted Stock Units that will vest over 1 to 3 years, each settling in one share of common stock.

What options did Christopher J. Meade exercise in this BlackRock (BLK) Form 4?

He exercised 18,095 Employee Stock Options with an exercise price of $513.50 per share, converting them into common stock. The option award covered 18,095 underlying shares and had an expiration date of December 4, 2026.

At what prices were Christopher J. Meade’s BlackRock (BLK) shares sold?

He sold 15,895 shares at a weighted-average price of $1,101.9936 and 2,200 shares at a weighted-average price of $1,102.7963. Each sale was executed through multiple trades within narrow intraday price ranges.

Do Christopher J. Meade’s remaining BlackRock (BLK) holdings include Restricted Stock Units?

Yes. The reported post-transaction holding of 14,059 shares includes Restricted Stock Units that will vest over a 1 to 3 year period. Each unit is payable solely by delivery of an equal number of BlackRock common shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Meade Christopher J.

(Last)(First)(Middle)
50 HUDSON YARDS

(Street)
NEW YORK NEW YORK 10001

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BlackRock, Inc. [ BLK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
General Counsel and CLO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/16/2026M18,095A$513.532,154(1)D
Common Stock07/16/2026S15,895D$1,101.9936(2)16,259(1)D
Common Stock07/16/2026S2,200D$1,102.7963(3)14,059(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$513.507/16/2026M18,095 (4)12/04/2026Common Stock18,095$00D
Explanation of Responses:
1. Includes Common Stock as well as Restricted Stock Units that will vest over a period of 1 to 3 years. Each Restricted Stock Unit is payable solely by delivery of an equal number of shares of Common Stock.
2. This transaction was executed in multiple trades at prices ranging from $1,101.43 to $1,102.34. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
3. This transaction was executed in multiple trades at prices ranging from $1,102.76 to $1,102.89. The price reported represents the weighted average sale price of these trades. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the shares sold at each separate price.
4. These options vested in equal installments on December 4, 2022, December 4, 2023 and December 4, 2024.
/s/ R. Andrew Dickson III as Attorney-in-Fact for Christopher J. Meade07/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)